Europe

Report: 43% of European consumers seek resources from pharma companies, not through social media

Tuesday, December 6, 2011 01:36 PM

More... »

AstraZeneca, MRC ink collaboration giving UK academia access to 22 compounds

Monday, December 5, 2011 02:14 PM

A wide range of compounds will be made available free of charge to UK medical researchers next year, following an agreement between the Medical Research Council (MRC) and AstraZeneca. Academia will be granted access to 22 compounds, developed by AstraZeneca. Through MRC funding, UK academia will conduct studies to better understand what drives a range of diseases with a view to exploring new treatment opportunities.

More... »

European Commission launches framework for research and innovation

Thursday, December 1, 2011 01:12 PM

EFPIA, the voice of the research-based pharmaceutical industry in Europe, welcomes the launch of the European Commission’s new Framework for Research and Innovation: Horizon 2020.

More... »

Imperial College and providers form partnership to improve healthcare in London

Wednesday, November 30, 2011 10:38 AM

Imperial College London and healthcare providers in North West London plan to form a partnership to improve the health and care of the local population of 1.9 million people.

More... »

University of Cambridge, Elan launch research center

Monday, November 28, 2011 03:21 PM

The University of Cambridge and Elan have launched The Cambridge-Elan Centre for Research Innovation and Drug Discovery (Cambridge-Elan Centre), which will be located at the University of Cambridge, England. The Cambridge-Elan Centre will provide an interdisciplinary environment uniquely positioned for delivering translational research focused on innovative therapies for Alzheimer's and Parkinson's diseases. This ten-year agreement paves the way for a long-term collaboration between Elan and the University of Cambridge.

More... »

Survey: ICON Medical Imaging rated top provider

Thursday, November 17, 2011 01:14 PM

Dublin-based ICON has reported that its Medical Imaging division was rated as the top provider of imaging services according to an industry survey conducted by Blue Pyramid Consulting, an affiliate of the Avoca Group.

More... »

Cardica enrolls first patients in MicroCutter study

Thursday, November 17, 2011 11:09 AM

Cardica has enrolled the first patients and discharged from the first two investigative sites in a European clinical study to evaluate its MicroCutter surgical cutting/stapling devices for transections, resections and anastomoses during gastrointestinal surgical procedures.

More... »

ICON's DOCS expands with four new offices in Europe

Wednesday, November 16, 2011 10:11 AM

ICON's resourcing division, DOCS, has expanded in Europe by opening four new offices: in Milan, Italy; Budapest, Hungary; Brussels, Belgium and Berlin, Germany. This latest expansion brings the total number of DOCS offices in Europe to 22.

More... »

Pantarhei Bioscience discovers ovarian cancer treatment

Monday, November 14, 2011 10:52 AM

Pantarhei Bioscience, a pharmaceutical company focusing on the development of  treatments in the fields of women’s health and endocrine cancer, has reported the results of an innovative treatment strategy for ovarian cancer. 

More... »

Report: Clinical trials approved in Russia on course in third quarter

Monday, November 7, 2011 11:26 AM

The number of new studies approved in Russia during the third quarter of 2011 reached last year’s level, with the Ministry of Health and Social Development of the Russian Federation (MoH) approving 132 new clinical trials of all types, including local and bioequivalence studies, according to Synergy Research Group (SynRG), a Russia-based CRO. That’s only two trials below the number approved in the year-ago quarter.

More... »